[Serologic diagnosis of Mycoplasma pneumoniae infections]

Area of Science:

• Medical Microbiology
• Immunology
• Infectious Diseases

Context:

• Mycoplasma pneumoniae is a widespread human pathogen responsible for 10-30% of community-acquired pneumonia cases.
• It presents with diverse clinical and radiological findings, often termed primary atypical pneumonia.
• The immune response involves rapid antibody production against microbial antigens, with IgM followed by IgG during primary infection and rising IgG/IgA in reinfections.

Purpose:

• To review diagnostic methods for Mycoplasma pneumoniae infections.
• To evaluate the utility of serological and molecular diagnostic techniques.
• To provide guidance on selecting appropriate diagnostic tests based on clinical context and patient demographics.

Summary:

• Microbiological diagnosis typically involves detecting specific antibodies, with common serological methods including complement fixation, immunofluorescence, particle agglutination, and enzyme immunoassay.
• Polymerase chain reaction (PCR) techniques, including multiplex PCR for identifying M. pneumoniae and other respiratory pathogens, show significant promise for routine diagnosis.
• Specific IgM antibody detection is not recommended for adults and young people, and seroconversion or rising IgG titers may lack clinical utility due to delays and difficulties in sample collection.

Impact:

• Highlights the limitations of traditional serological diagnostic criteria for Mycoplasma pneumoniae.
• Emphasizes the potential of PCR-based methods for timely and accurate diagnosis of M. pneumoniae infections.
• Informs clinical practice regarding the appropriate selection of diagnostic tests for community-acquired pneumonia.